Quest Diagnostics launches pharmacogenomics testing service
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Quest Diagnostics (NYSE: DGX) | Delayed: 241.70 -1.58 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $243.28 | 52 Week High | $86.85 | |||
| Open | $239.63 | 52 Week Low | $59.66 | |||
| Day High | $243.90 | P/E | 45.52 | |||
| Day Low | $239.63 | EPS | $5.31 | |||
| Volume | 197,787 | |||||
